OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Merck & CO INC MERCK & CO ORD (CD.../  US58933Y1055  /

London Domestic
2024-04-29  4:46:12 PM Chg. - Volume Bid5:35:14 PM Ask5:35:14 PM Market Capitalization Dividend Y. P/E Ratio
131.26USD - 201,318
Turnover: -		 -Bid Size: - -Ask Size: - 331.5 bill.USD 2.26% 934.93
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B
TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices
TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B
TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs
TeleTrader 2023-06-06 WH defends Medicare over Merck lawsuit
TeleTrader 2023-06-06 Merck sues US gov't over drug price negotiations
TeleTrader 2023-04-27 Merck's Q1 sales land at $14.5B, down 9%
TeleTrader 2023-04-16 Merck reportedly in talks to buy Prometheus Biosciences
TeleTrader 2023-02-24 EU regulator recommends against Merck's COVID drug
TeleTrader 2023-02-02 Merck posts Q4 sales up 2% to $13.8B
TeleTrader 2023-01-13 J&J reportedly cuts COVID vaccine production
TeleTrader 2022-12-30 China greenlights import of Merck's COVID pill
TeleTrader 2022-12-13 Moderna soars 22% on cancer vaccine breakthrough
TeleTrader 2022-12-13 Moderna soars 8% premarket on cancer vaccine results
TeleTrader 2022-12-12 Merck starts tender offer for Imago BioSciences at $36 per share
TeleTrader 2022-10-27 Merck: Q3 sales increase 14% to $14.96B
TeleTrader 2022-07-28 Merck: EPS more than triples to $1.55 in Q2
TeleTrader 2022-06-17 Merck discussing buying Seagen for $28B - report
TeleTrader 2022-04-28 Merck's Q1 EPS up 57% to $1.70
TeleTrader 2022-03-16 Merck halts new Russia investments
TeleTrader 2022-02-03 Merck's sales up by 24% to $13.52 billion in Q4
TeleTrader 2022-01-18 Merck, Ridgeback to supply 3 million courses of molnupiravir
GlobeNewswire 2022-01-11 Aligos Therapeutics Expands Collaboration with Merck to Develop Oligonucleotide Therapies for NASH
TeleTrader 2021-12-28 India approves use of Merck's COVID-19 pill